North America and Europe Stroke Diagnostics Market Analysis Report By Technology (MRI, CT Scan, Carotid Ultrasound, Cerebral Angiography, Nuclear Imaging), And Segment Forecasts, 2018 - 2024
This report can be delivered to the clients within Immediate
The North America and Europe stroke diagnostics market size is expected to reach USD 2.35 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.2% over the forecast period. Rising geriatric population in countries like U.S. and Germanyhas led to high growth of the market. Geriatric population in U.S. is anticipated to rise to around 98 million by 2060.
Unhealthy lifestyle is another significant factor driving demand for stroke diagnostic products. Unhealthy lifestyles and physical inactivity are attributed to rising cases of diabetes, obesity, and other such health conditions. According to the Centers for Disease Control and Prevention (CDC) 2017 statistics, over 36% of U.S. population is obese. Diabetes is also one of the prevalent health conditions in Europe. Thus, increasing incidence of such disease conditions has propelled the market for stroke diagnostics.
Rise in awareness among people pertaining to stroke diagnosis and treatment is also expected to foster market growth. In 2011, the Department of Health and Human Services in U.S. started the Million Hearts program as an initiative to avert strokes by 2017. Building on the experience of the first five years the program is committed to work towards prevention of 1 million strokes. The program aims at taking steps to prevent cardiovascular diseases, such as strokes and improving overall public health. Such awareness programs undertaken by government are likely to boost the market growth.
Further key findings from the study suggest:
CT scan was the dominant technology segment in 2016 due to its high usage rate for stroke evaluation and is considered as a preliminary testing technique
Carotid ultrasound segment is anticipated to showcase lucrative CAGR during the forecast period owing to the advantages like noninvasive technique and cost-effectiveness
MRI segment held significant revenue share in 2016 owing to innovations and advancements for improved diagnosis
Cerebral angiography is expected to exhibit lucrative growth during the forecast period owing to rising adoption of minimally invasive diagnostic techniques
North America held the largest market share in 2016 due to rise in unhealthy lifestyles leading to obesity and diabetes, especially in U.S. Europe contributed to significant market share due to increasing geriatric population in Germany
Some of the key manufacturers in the North America and Europe stroke diagnostics market are Cordis Corporation, Siemens Healthineers, GE Healthcare, Toshiba Medical Systems Corporation, Boston Scientific Corporation, Hitachi Medical Systems, Neusoft Medical Systems, and Philips Healthcare.
The North America and Europe stroke diagnostics market size is expected to reach USD 2.35 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.2% over the forecast period. Rising geriatric population in countries like U.S. and Germanyhas led to high growth of the market. Geriatric population in U.S. is anticipated to rise to around 98 million by 2060.
Unhealthy lifestyle is another significant factor driving demand for stroke diagnostic products. Unhealthy lifestyles and physical inactivity are attributed to rising cases of diabetes, obesity, and other such health conditions. According to the Centers for Disease Control and Prevention (CDC) 2017 statistics, over 36% of U.S. population is obese. Diabetes is also one of the prevalent health conditions in Europe. Thus, increasing incidence of such disease conditions has propelled the market for stroke diagnostics.
Rise in awareness among people pertaining to stroke diagnosis and treatment is also expected to foster market growth. In 2011, the Department of Health and Human Services in U.S. started the Million Hearts program as an initiative to avert strokes by 2017. Building on the experience of the first five years the program is committed to work towards prevention of 1 million strokes. The program aims at taking steps to prevent cardiovascular diseases, such as strokes and improving overall public health. Such awareness programs undertaken by government are likely to boost the market growth.
Further key findings from the study suggest:
CT scan was the dominant technology segment in 2016 due to its high usage rate for stroke evaluation and is considered as a preliminary testing technique
Carotid ultrasound segment is anticipated to showcase lucrative CAGR during the forecast period owing to the advantages like noninvasive technique and cost-effectiveness
MRI segment held significant revenue share in 2016 owing to innovations and advancements for improved diagnosis
Cerebral angiography is expected to exhibit lucrative growth during the forecast period owing to rising adoption of minimally invasive diagnostic techniques
North America held the largest market share in 2016 due to rise in unhealthy lifestyles leading to obesity and diabetes, especially in U.S. Europe contributed to significant market share due to increasing geriatric population in Germany
Some of the key manufacturers in the North America and Europe stroke diagnostics market are Cordis Corporation, Siemens Healthineers, GE Healthcare, Toshiba Medical Systems Corporation, Boston Scientific Corporation, Hitachi Medical Systems, Neusoft Medical Systems, and Philips Healthcare.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. North America & Europe stroke diagnostics market - Industry summary and key buying criteria, 2013 - 2024
CHAPTER 3. MARKET SNAPSHOT
CHAPTER 4. MARKET VARIABLES, TRENDS & SCOPE
4.1. Market segmentation & scopes
4.2. North America & Europe stroke diagnostics: Market dynamics
4.2.1. Market driver analysis
4.2.1.1. Growing geriatric population
4.2.1.2. Increasing adoption of unhealthy lifestyle
4.2.1.3. Increasing awareness among the population
4.2.2. Market restraint analysis
4.2.2.1. Decline in the stroke incidence rates
4.3. North America & Europe stroke diagnostics - SWOT analysis, by factor (political & legal, economic and technological)
4.4. Industry analysis - Porter’s five forces analysis
4.5. Key opportunities prioritized
4.6. North America & Europe stroke diagnostics: Company share analysis, 2015
CHAPTER 5. NORTH AMERICA & EUROPE STROKE DIAGNOSTICS MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1. North America & Europe stroke diagnostics market: Technology movement analysis
5.2. Magnetic Resonance Imaging
5.2.1. Market Estimates and Forecast, 2013 to 2024 (USD Million)
5.3. Computed Tomography Scan
5.3.1. Market Estimates and Forecast, 2013 to 2024 (USD Million)
5.4. Carotid Ultrasound
5.4.1. Market Estimates and Forecast, 2013 to 2024 (USD Million)
5.5. Cerebral Angiography
5.5.1. Market Estimates and Forecast, 2013 to 2024 (USD Million)
5.6. Nuclear Imaging
5.6.1. Market Estimates and Forecast, 2013 to 2024 (USD Million)
5.7. Others
5.7.1. Market Estimates and Forecast, 2013 to 2024 (USD Million)
CHAPTER 6. STROKE DIAGNOSTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY TECHNOLOGY
6.1. Stroke Diagnostics Market Share (%) Analysis, by Region, 2016 & 2024
6.2. North America
6.2.1. U.S.
6.2.1.1. U.S. stroke diagnostics market, by technology, 2013 - 2024 (USD Million)
6.2.2. Canada
6.2.2.1. Canada stroke diagnostics market, by technology, 2013 - 2024 (USD Million)
6.3. Europe
6.3.1. Germany
6.3.1.1. Germany stroke diagnostics market, by technology, 2013 - 2024 (USD Million)
6.3.2. U.K.
6.3.2.1. U.K. stroke diagnostics market, by technology, 2013 - 2024 (USD Million)
6.3.3. Spain
6.3.3.1. Spain stroke diagnostics market, by technology, 2013 - 2024 (USD Million)
6.3.4. Italy
6.3.4.1. Italy stroke diagnostics market, by technology, 2013 - 2024 (USD Million)
6.3.5. France
6.3.5.1. France stroke diagnostics market, by technology, 2013 - 2024 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Company Profiles
7.1.1. Siemens Healthcare
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. Cordis Corporation
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Boston Scientific Corp.
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. GE Healthcare
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Philips Healthcare
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Toshiba Medical Systems Corporation
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Hitachi Medical Systems
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.7.5. Strategic Initiatives
7.1.8. Neusoft Medical Systems
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. North America & Europe stroke diagnostics market - Industry summary and key buying criteria, 2013 - 2024
CHAPTER 3. MARKET SNAPSHOT
CHAPTER 4. MARKET VARIABLES, TRENDS & SCOPE
4.1. Market segmentation & scopes
4.2. North America & Europe stroke diagnostics: Market dynamics
4.2.1. Market driver analysis
4.2.1.1. Growing geriatric population
4.2.1.2. Increasing adoption of unhealthy lifestyle
4.2.1.3. Increasing awareness among the population
4.2.2. Market restraint analysis
4.2.2.1. Decline in the stroke incidence rates
4.3. North America & Europe stroke diagnostics - SWOT analysis, by factor (political & legal, economic and technological)
4.4. Industry analysis - Porter’s five forces analysis
4.5. Key opportunities prioritized
4.6. North America & Europe stroke diagnostics: Company share analysis, 2015
CHAPTER 5. NORTH AMERICA & EUROPE STROKE DIAGNOSTICS MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1. North America & Europe stroke diagnostics market: Technology movement analysis
5.2. Magnetic Resonance Imaging
5.2.1. Market Estimates and Forecast, 2013 to 2024 (USD Million)
5.3. Computed Tomography Scan
5.3.1. Market Estimates and Forecast, 2013 to 2024 (USD Million)
5.4. Carotid Ultrasound
5.4.1. Market Estimates and Forecast, 2013 to 2024 (USD Million)
5.5. Cerebral Angiography
5.5.1. Market Estimates and Forecast, 2013 to 2024 (USD Million)
5.6. Nuclear Imaging
5.6.1. Market Estimates and Forecast, 2013 to 2024 (USD Million)
5.7. Others
5.7.1. Market Estimates and Forecast, 2013 to 2024 (USD Million)
CHAPTER 6. STROKE DIAGNOSTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY TECHNOLOGY
6.1. Stroke Diagnostics Market Share (%) Analysis, by Region, 2016 & 2024
6.2. North America
6.2.1. U.S.
6.2.1.1. U.S. stroke diagnostics market, by technology, 2013 - 2024 (USD Million)
6.2.2. Canada
6.2.2.1. Canada stroke diagnostics market, by technology, 2013 - 2024 (USD Million)
6.3. Europe
6.3.1. Germany
6.3.1.1. Germany stroke diagnostics market, by technology, 2013 - 2024 (USD Million)
6.3.2. U.K.
6.3.2.1. U.K. stroke diagnostics market, by technology, 2013 - 2024 (USD Million)
6.3.3. Spain
6.3.3.1. Spain stroke diagnostics market, by technology, 2013 - 2024 (USD Million)
6.3.4. Italy
6.3.4.1. Italy stroke diagnostics market, by technology, 2013 - 2024 (USD Million)
6.3.5. France
6.3.5.1. France stroke diagnostics market, by technology, 2013 - 2024 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Company Profiles
7.1.1. Siemens Healthcare
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. Cordis Corporation
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Boston Scientific Corp.
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. GE Healthcare
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Philips Healthcare
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Toshiba Medical Systems Corporation
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Hitachi Medical Systems
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.7.5. Strategic Initiatives
7.1.8. Neusoft Medical Systems
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
LIST OF TABLES
1. North America and Europe stroke diagnostics - Industry Snapshot & Key Buying Criteria, 2013 - 2024
2. North America and Europe stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
3. North America and Europe stroke diagnostics market, by region, 2013 - 2024 (USD Million)
4. North America and Europe stroke diagnostics - Key Market Driver Analysis
5. North America and Europe stroke diagnostics - Key Market Restraint Analysis
6. North America stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
7. U.S. stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
8. Canada stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
9. Europe stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
10. Germany stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
11. U.K. stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
12. France stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
13. Italy stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
14. Spain stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
1. North America and Europe stroke diagnostics - Industry Snapshot & Key Buying Criteria, 2013 - 2024
2. North America and Europe stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
3. North America and Europe stroke diagnostics market, by region, 2013 - 2024 (USD Million)
4. North America and Europe stroke diagnostics - Key Market Driver Analysis
5. North America and Europe stroke diagnostics - Key Market Restraint Analysis
6. North America stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
7. U.S. stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
8. Canada stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
9. Europe stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
10. Germany stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
11. U.K. stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
12. France stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
13. Italy stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
14. Spain stroke diagnostics market revenue, by technology, 2013 - 2024 (USD Million)
LIST OF FIGURES
1. North America and Europe stroke diagnostics: Market segmentation
2. North America and Europe stroke diagnostics, 2013 - 2024 (USD Million)
3. North America and Europe stroke diagnostics market: Industry trend analysis
4. North America and Europe stroke diagnostics market: PEST analysis
5. North America and Europe stroke diagnostics market: Porter’s analysis
6. North America and Europe stroke diagnostics: Company market share, 2015
7. Key Opportunities Prioritized
8. North America and Europe stroke diagnostics market revenue share by technology, 2016 & 2024
9. Magnetic resonance imaging market revenue, 2013 to 2024 (USD Million)
10. Computed tomography scan market revenue, 2013 to 2024 (USD Million)
11. Nuclear imaging market revenue, 2013 to 2024 (USD Million)
12. Carotid ultrasound market revenue, 2013 to 2024 (USD Million)
13. Cerebral angiography market revenue, 2013 to 2024 (USD Million)
14. Others market revenue, 2013 to 2024 (USD Million)
15. North America and Europe stroke diagnostics market share, by region, 2016 & 2024
1. North America and Europe stroke diagnostics: Market segmentation
2. North America and Europe stroke diagnostics, 2013 - 2024 (USD Million)
3. North America and Europe stroke diagnostics market: Industry trend analysis
4. North America and Europe stroke diagnostics market: PEST analysis
5. North America and Europe stroke diagnostics market: Porter’s analysis
6. North America and Europe stroke diagnostics: Company market share, 2015
7. Key Opportunities Prioritized
8. North America and Europe stroke diagnostics market revenue share by technology, 2016 & 2024
9. Magnetic resonance imaging market revenue, 2013 to 2024 (USD Million)
10. Computed tomography scan market revenue, 2013 to 2024 (USD Million)
11. Nuclear imaging market revenue, 2013 to 2024 (USD Million)
12. Carotid ultrasound market revenue, 2013 to 2024 (USD Million)
13. Cerebral angiography market revenue, 2013 to 2024 (USD Million)
14. Others market revenue, 2013 to 2024 (USD Million)
15. North America and Europe stroke diagnostics market share, by region, 2016 & 2024
